Epidemiological characteristics and treatment patterns of Alport syndrome in Korea
Kidney Research and Clinical Practice · 02.04.2026
DOI: 10.23876/j.krcp.25.348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, online erschienen am 02.04.2026. Verfasst von Min Ji Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Abstract (Originalsprache)
Background
Alport syndrome is the second most common inherited kidney disease, yet many patients remain undiagnosed until advanced kidney failure or receive inappropriate immunosuppressive therapy. Genetic testing indicates it is more common than recognized, but most epidemiological studies have been regional, lacking nationwide assessments.
Methods
We analyzed Korean National Health Insurance data, covering the entire population. Patients were identified using the rare disease registration code (V267), requiring laboratory and genetic or histopathological confirmation. We estimated prevalence and incidence, examined therapeutic history before diagnosis, and assessed treatment patterns, particularly renin-angiotensin system (RAS) inhibition.
Results
In 2023, 788 prevalent cases (15.5 per million) were identified; fewer than 10% of the estimated 8,800 COL4A5 male carriers are registered. From 2014 to 2023, 529 incident cases were recorded with a steadily rising incidence. At diagnosis, 30% had been labeled with other glomerulonephritis, with 15% receiving immunosuppressants and 58% RAS inhibitors. After diagnosis, RAS inhibitor use increased by 25%, but immunosuppressive therapy persisted.
Conclusion
This nationwide analysis of registered Alport syndrome cases suggests potential underdiagnosis in Korea, with delays in appropriate recognition and treatment. Many patients receive unnecessary immunosuppression due to misdiagnosis, underscoring the need for improved diagnostic awareness and broader genetic testing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
- Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
- Division of Pediatric Nephrology, Severance Children's Hospital, Seoul, Republic of Korea.
- Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Department of Pediatrics, Ajou University School of Medicine, Suwon, Republic of Korea.
Zitieren
APA
Park, M. J., Kim, J. H., Lee, K. H., Cho, M. H., & Park, P. G. (2026). Epidemiological characteristics and treatment patterns of Alport syndrome in Korea. Kidney Research and Clinical Practice. https://doi.org/10.23876/j.krcp.25.348
Vancouver
Park MJ, Kim JH, Lee KH, Cho MH, Park PG. Epidemiological characteristics and treatment patterns of Alport syndrome in Korea. Kidney Research and Clinical Practice. 2026. doi:10.23876/j.krcp.25.348
BibTeX
@article{Park2026,
author = {Park, Min Ji and Kim, Ji Hyun and Lee, Keum Hwa and Cho, Min Hyun and Park, Peong Gang},
title = {Epidemiological characteristics and treatment patterns of Alport syndrome in Korea},
journal = {Kidney Research and Clinical Practice},
year = {2026},
doi = {10.23876/j.krcp.25.348}
}
EUVIMED